Hageman factor-independent fibrinolytic pathway.
- 1 August 1974
- journal article
- Vol. 17 (4), 587-600
Abstract
The lysis of clots formed by the addition of thrombin to dilute whole plasma containing 125I-labelled fibrinogen was examined in kinetic assays which assessed clot size and release of radiolabel into the lysate. Neither platelets, immunoglobulin, nor Hageman factor was essential for clot lysis in this system. Clot lysis was normal in plasma from patients genetically deficient in either C2 or C6 but abnormal in the plasma of two patients with acquired C3 deficiency. Plateletdeficient plasma depleted of C3 by cobra venom factor or adsorbed with zymosan did not sustain clot lysis. These findings indicate the existence of a humoral fibrinolytic pathway in whole human plasma dependent upon C3 but independent of Hageman factor.This publication has 24 references indexed in Scilit:
- PROPERDIN FACTOR D: CHARACTERIZATION OF ITS ACTIVE SITE AND ISOLATION OF THE PRECURSOR FORMThe Journal of Experimental Medicine, 1974
- Inhibition by CāINH of Hageman Factor Fragment Activation of Coagulation, Fibrinolysis, and Kinin GenerationJournal of Clinical Investigation, 1973
- Properdin and C3 Proactivator: Alternate Pathway Components in Human GlomerulonephritisJournal of Clinical Investigation, 1973
- THE FIBRINOLYTIC PATHWAY OF HUMAN PLASMAThe Journal of Experimental Medicine, 1972
- MOLECULAR ANALYSIS OF THE MEMBRANE ATTACK MECHANISM OF COMPLEMENTThe Journal of Experimental Medicine, 1972
- Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of plateletsJournal of Clinical Investigation, 1970
- Hereditary deficiency of the second component of complement (C2) in man: correlation of C2 haemolytic activity with immunochemical measurements of C2 protein.1970
- Two Anticomplementary Factors in Cobra Venom: Hemolysis of Guinea Pig Erythrocytes by One of ThemThe Journal of Immunology, 1969
- FORMATION AND FUNCTIONAL SIGNIFICANCE OF A MOLECULAR COMPLEX DERIVED FROM THE SECOND AND THE FOURTH COMPONENT OF HUMAN COMPLEMENTThe Journal of Experimental Medicine, 1967
- EPSILON-AMINOCAPROIC ACID - INHIBITOR OF PLASMINOGEN ACTIVATION1959